LABETALOL HCL 300 MG TABLET

Labetalol Hydrochloride
$0.2041per EA

Strength

300 mg/1

Manufacturer

Innogenix, Inc.

NDC

71247013001

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Last Updated

2/18/2026

Active Ingredients

LABETALOL HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA075215

On Market Since

2/8/2021

Pharmacological Classes

Adrenergic beta-Antagonists
beta-Adrenergic Blocker

Price History

1W

0.0%

1M

0.0%

3M

-2.8%

6M

-1.3%

1Y

+1.9%

3Y

-2.4%

5Y

N/A

All

-15.1%